Enriched KEGG pathways among predicted gene targets of deregulated miRNAs in NKTL
| KEGGID . | P . | Odds ratio . | Count . | Size . | Term . | Genes . |
|---|---|---|---|---|---|---|
| 770 | .00005 | 22.96432681 | 4 | 15 | Pantothenate and CoA biosynthesis | BCAT1, BCAT2, PANK1, PANK3 |
| 290 | .00044 | 23.4 | 3 | 11 | Valine, leucine, and isoleucine biosynthesis | BCAT1, BCAT2, IARS |
| 4115 | .00055 | 6.206116464 | 6 | 68 | p53 signaling pathway | CASP3, CCNE1, CHEK1, IGF1, CCNE2, BBC3 |
| 4110 | .00057 | 4.531014493 | 8 | 123 | Cell cycle | CCNE1, CDC25A, CHEK1, MAD2L1, TFDP1, TTK, WEE1, CCNE2 |
| 4114 | .00155 | 4.293859649 | 7 | 112 | Oocyte meiosis | ADCY3, ADCY8, CCNE1, IGF1, IGF1R, MAD2L1, CCNE2 |
| 4914 | .00175 | 4.853855006 | 6 | 85 | Progesterone-mediated oocyte maturation | ADCY3, ADCY8, CDC25A, IGF1, IGF1R, MAD2L1 |
| 5215 | .00945 | 3.844590369 | 5 | 87 | Prostate cancer | BCL2, CCNE1, IGF1, IGF1R, CCNE2 |
| 4510 | .00994 | 2.730212766 | 8 | 196 | Focal adhesion | BCL2, CDC42, ELK1, IGF1, IGF1R, MYLK, VEGFA, TLN2 |
| 4912 | .01513 | 3.38227185 | 5 | 98 | GnRH signaling pathway | ADCY3, ADCY8, CDC42, HBEGF, ELK1 |
| 4614 | .02164 | 8.205761317 | 2 | 17 | Renin-angiotensin system | ENPEP, NLN |
| 5210 | .03373 | 3.113924051 | 4 | 84 | Colorectal cancer | BCL2, CASP3, IGF1R, ACVR1C |
| 4150 | .03533 | 3.868 75 | 3 | 51 | mTOR signaling pathway | IGF1, VEGFA, DDIT4 |
| 5414 | .03884 | 2.963230862 | 4 | 88 | Dilated cardiomyopathy | ADCY3, ADCY8, ATP2A2, IGF1 |
| 4010 | .04517 | 1.984836601 | 8 | 263 | MAPK signaling pathway | CASP3, CDC42, DUSP4, ELK1, FGF7, STMN1, NTRK2, ACVR1C |
| 52 | .04708 | 5.119341564 | 2 | 26 | Galactose metabolism | GCK, B4GALT2 |
| 450 | .04708 | 5.119341564 | 2 | 26 | Seleno amino acid metabolism | AHCY, CTH |
| KEGGID . | P . | Odds ratio . | Count . | Size . | Term . | Genes . |
|---|---|---|---|---|---|---|
| 770 | .00005 | 22.96432681 | 4 | 15 | Pantothenate and CoA biosynthesis | BCAT1, BCAT2, PANK1, PANK3 |
| 290 | .00044 | 23.4 | 3 | 11 | Valine, leucine, and isoleucine biosynthesis | BCAT1, BCAT2, IARS |
| 4115 | .00055 | 6.206116464 | 6 | 68 | p53 signaling pathway | CASP3, CCNE1, CHEK1, IGF1, CCNE2, BBC3 |
| 4110 | .00057 | 4.531014493 | 8 | 123 | Cell cycle | CCNE1, CDC25A, CHEK1, MAD2L1, TFDP1, TTK, WEE1, CCNE2 |
| 4114 | .00155 | 4.293859649 | 7 | 112 | Oocyte meiosis | ADCY3, ADCY8, CCNE1, IGF1, IGF1R, MAD2L1, CCNE2 |
| 4914 | .00175 | 4.853855006 | 6 | 85 | Progesterone-mediated oocyte maturation | ADCY3, ADCY8, CDC25A, IGF1, IGF1R, MAD2L1 |
| 5215 | .00945 | 3.844590369 | 5 | 87 | Prostate cancer | BCL2, CCNE1, IGF1, IGF1R, CCNE2 |
| 4510 | .00994 | 2.730212766 | 8 | 196 | Focal adhesion | BCL2, CDC42, ELK1, IGF1, IGF1R, MYLK, VEGFA, TLN2 |
| 4912 | .01513 | 3.38227185 | 5 | 98 | GnRH signaling pathway | ADCY3, ADCY8, CDC42, HBEGF, ELK1 |
| 4614 | .02164 | 8.205761317 | 2 | 17 | Renin-angiotensin system | ENPEP, NLN |
| 5210 | .03373 | 3.113924051 | 4 | 84 | Colorectal cancer | BCL2, CASP3, IGF1R, ACVR1C |
| 4150 | .03533 | 3.868 75 | 3 | 51 | mTOR signaling pathway | IGF1, VEGFA, DDIT4 |
| 5414 | .03884 | 2.963230862 | 4 | 88 | Dilated cardiomyopathy | ADCY3, ADCY8, ATP2A2, IGF1 |
| 4010 | .04517 | 1.984836601 | 8 | 263 | MAPK signaling pathway | CASP3, CDC42, DUSP4, ELK1, FGF7, STMN1, NTRK2, ACVR1C |
| 52 | .04708 | 5.119341564 | 2 | 26 | Galactose metabolism | GCK, B4GALT2 |
| 450 | .04708 | 5.119341564 | 2 | 26 | Seleno amino acid metabolism | AHCY, CTH |